ProShare Advisors’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $91.7K | Sell |
|
|||||
|
2024
Q4 | $119K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $110K | Buy |
|
|||||
|
2023
Q4 | $132K | Buy |
|
|||||
|
2023
Q3 | $93K | Sell |
|
|||||
|
2023
Q2 | $122K | Sell |
|
|||||
|
2023
Q1 | $134K | Sell |
|
|||||
|
2022
Q4 | $157K | Buy |
|
|||||
|
2022
Q3 | $137K | Buy |
|
|||||
|
2022
Q2 | $119K | Sell |
|
|||||
|
2022
Q1 | $181K | Sell |
|
|||||
|
2021
Q4 | $260K | Buy |
|
|||||
|
2021
Q3 | $173K | Sell |
|
|||||
|
2021
Q2 | $371K | Buy |
|
|||||
|
2021
Q1 | $436K | Buy |
|
|||||
|
2020
Q4 | $359K | Buy |
|
|||||
|
2020
Q3 | $235K | Sell |
|
|||||
|
2020
Q2 | $343K | Buy |
|
|||||
|
2020
Q1 | $247K | Sell |
|
|||||
|
2019
Q4 | $475K | Sell |
|
|||||
|
2019
Q3 | $397K | Sell |
|
|||||
|
2019
Q2 | $343K | Sell |
|
|||||
|
2019
Q1 | $535K | Buy |
|
|||||
|
2018
Q4 | $597K | Sell |
|
|||||
|
2018
Q3 | $905K | Sell |
|
|||||
|
2018
Q2 | $651K | Sell |
|
|||||
|
2018
Q1 | $741K | Sell |
|
|||||
|
2017
Q4 | $986K | Buy |
|
|||||
|
2017
Q3 | $1.14M | Buy |
|
|||||
|
2017
Q2 | $1.24M | Sell |
|
|||||
|
2017
Q1 | $1.19M | Sell |
|
|||||
|
2016
Q4 | $1.3M | Buy |
|
|||||
|
2016
Q3 | $1.25M | Sell |
|
|||||
|
2016
Q2 | $903K | Buy |
|
|||||
|
2016
Q1 | $592K | Sell |
|
|||||
|
2015
Q4 | $567K | Buy |
|
|||||
|
2015
Q3 | $311K | Sell |
|
|||||
|
2015
Q2 | $394K | Sell |
|
|||||
|
2015
Q1 | $529K | Buy |
|
|||||
|
2014
Q4 | $394K | Buy |
|
|||||
|
2014
Q3 | $215K | Sell |
|
|||||
|
2014
Q2 | $393K | Buy |
|